FGP
ACHC icon

Freestone Grove Partners’s Acadia Healthcare ACHC Stock Holding History

Freestone Grove Partners’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19M Buy
643,486
+7,370
+1% +$189K 0.12% 209
2026
Q1 		$14.9M Buy
+636,116
New +$11.5M 0.11% 246
2025
Q1 		– Sell
-755,178
Closed -$29.9M – 572
2024
Q4 		$29.9M Buy
+755,178
New +$34.1M 0.37% 96

Other funds holding ACHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Freestone Grove Partners's ACHC Position: Q2 2026 in Review

Freestone Grove Partners increased its Acadia Healthcare (ACHC) stake by 1.2% in Q2 2026, buying an estimated $189K and bringing the position to 643,486 shares worth $19M. The position accounts for 0.12% of the portfolio, ranked #209.

Freestone Grove Partners first reported a position in ACHC in Q4 2024 and has held it in 3 quarters since. The position peaked at $29.9M in Q4 2024. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Freestone Grove Partners held 643,486 shares of Acadia Healthcare worth $19M as of Q2 2026.
  • Freestone Grove Partners bought 7,370 Acadia Healthcare shares in Q2 2026, an estimated $189K.
  • Acadia Healthcare made up 0.12% of Freestone Grove Partners's portfolio in Q2 2026, its #209 holding.
  • Freestone Grove Partners first reported a position in Acadia Healthcare in Q4 2024 and has held it in 3 quarters since.
  • Freestone Grove Partners's Acadia Healthcare position peaked at $29.9M in Q4 2024.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.